FR2734482B1 - NEW USE OF BETA3-ADRENERGIC AGONIST COMPOUNDS - Google Patents

NEW USE OF BETA3-ADRENERGIC AGONIST COMPOUNDS

Info

Publication number
FR2734482B1
FR2734482B1 FR9512694A FR9512694A FR2734482B1 FR 2734482 B1 FR2734482 B1 FR 2734482B1 FR 9512694 A FR9512694 A FR 9512694A FR 9512694 A FR9512694 A FR 9512694A FR 2734482 B1 FR2734482 B1 FR 2734482B1
Authority
FR
France
Prior art keywords
beta3
new use
adrenergic agonist
agonist compounds
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9512694A
Other languages
French (fr)
Other versions
FR2734482A1 (en
Inventor
Cyril Jacques Bouloux
Luciano Manara
Stephen Robert Bloom
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9504448A external-priority patent/FR2732894B1/en
Application filed by Sanofi SA filed Critical Sanofi SA
Priority to FR9512694A priority Critical patent/FR2734482B1/en
Priority to BE9600294A priority patent/BE1009698A3/en
Priority to IT96TO000284A priority patent/IT1298492B1/en
Publication of FR2734482A1 publication Critical patent/FR2734482A1/en
Application granted granted Critical
Publication of FR2734482B1 publication Critical patent/FR2734482B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR9512694A 1995-04-13 1995-10-27 NEW USE OF BETA3-ADRENERGIC AGONIST COMPOUNDS Expired - Fee Related FR2734482B1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR9512694A FR2734482B1 (en) 1995-04-13 1995-10-27 NEW USE OF BETA3-ADRENERGIC AGONIST COMPOUNDS
BE9600294A BE1009698A3 (en) 1995-04-13 1996-04-09 NEW USE OF 3-ADRENERGIC AGONIST COMPOUNDS.
IT96TO000284A IT1298492B1 (en) 1995-04-13 1996-04-12 USE OF BETA3-ADRENERGIC AGONIST COMPOUNDS FOR THE PREPARATION OF DRUGS CAPABLE OF INDURING THE RELEASE OF THE "GLP-1" HORMONE

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9504448A FR2732894B1 (en) 1995-04-13 1995-04-13 NEW USE OF BETA9-ADRENERGIC AGONIST COMPOUNDS
FR9512694A FR2734482B1 (en) 1995-04-13 1995-10-27 NEW USE OF BETA3-ADRENERGIC AGONIST COMPOUNDS

Publications (2)

Publication Number Publication Date
FR2734482A1 FR2734482A1 (en) 1996-11-29
FR2734482B1 true FR2734482B1 (en) 1997-08-14

Family

ID=26231888

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9512694A Expired - Fee Related FR2734482B1 (en) 1995-04-13 1995-10-27 NEW USE OF BETA3-ADRENERGIC AGONIST COMPOUNDS

Country Status (3)

Country Link
BE (1) BE1009698A3 (en)
FR (1) FR2734482B1 (en)
IT (1) IT1298492B1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5106867A (en) * 1990-05-04 1992-04-21 American Cyanamid Company Method of increasing lean meat in edible animals
US5061727A (en) * 1990-05-04 1991-10-29 American Cyanamid Company Substituted 5-(2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxoles
JPH06345731A (en) * 1992-04-28 1994-12-20 Dainippon Pharmaceut Co Ltd 2-(2-(indol-3-ly)ethylamino)-1-phenylethanol derivative

Also Published As

Publication number Publication date
ITTO960284A0 (en) 1996-04-12
IT1298492B1 (en) 2000-01-10
ITTO960284A1 (en) 1997-10-12
BE1009698A3 (en) 1997-07-01
FR2734482A1 (en) 1996-11-29

Similar Documents

Publication Publication Date Title
MA23800A1 (en) NEW COMPOSITION
PT802910E (en) AGONISTS / ANTAGONISTS OF ESTROGEN
FI980033A (en) Inhibitors of cell attachment
DK1445259T3 (en) Use of crystal forms for 2-methyl-thieno-benzodiazepine
BR9607097A (en) New compounds
FI20030370A (en) New compounds
NO982850D0 (en) New synthesis
NO961887L (en) -adrenergic agonists
DK0788496T3 (en) Inhibitors for the synthesis of apolipoprotein-B
DK0820451T3 (en) New Heterocyclic Compounds
NO976143D0 (en) Use of at least one <beta> -adrenergic agonist as a P substance antagonist
BR9600039A (en) Toner composition
FR2742661B1 (en) NEW USE OF NACRE-CONTAINING COMPOSITIONS
MA23794A1 (en) USE OF PHENYLCYCLOHEXYLCARBOXAMIDES
FR2732894B1 (en) NEW USE OF BETA9-ADRENERGIC AGONIST COMPOUNDS
MA23799A1 (en) NEW COMPOSITION
FR2734482B1 (en) NEW USE OF BETA3-ADRENERGIC AGONIST COMPOUNDS
FI953319A0 (en) Manufacture of dimethylnaphthalene
FR2744447B1 (en) USE OF TETRAHYDROISOQUINOLEIN DERIVATIVES
NO305946B1 (en) Retinoid-like compounds
KR970003380U (en) Jeonju Reserve
PT761766E (en) ASYMPHETRIC COMPOUNDS OF TRIFENYLENEOXAZINE
BR9502118A (en) Adapter
SE9502626L (en) Adapter
KR970014847U (en) Toner fusion inhibitor of doctor blade

Legal Events

Date Code Title Description
CA Change of address
TP Transmission of property
CD Change of name or company name
ST Notification of lapse

Effective date: 20130628